908 Devices Inc Aktie News

908 Devices Inc. (NASDAQ:MASS ) Q1 2024 Results Conference Call April 30, 2024 8:30 AM ET Company Participants Kelly Gura - Investor Relations Kevin Knopp - Co-Founder and Chief Executive Officer Joe Griffith - Chief Financial Officer Conference Call Participants Matt Larew - William Blair Jacob Johnson - Stephens Steven Mah - TD Cowen Dan Arias - Stifel Puneet Souda - Leerink Partners Operator...

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today reported financial results for the quarter ended March 31, 2024. "We had a solid start to the year with topline revenue of $10 million for the first quarter and continued to see robust demand for our handheld devices as applications for c...

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biochemical analysis, announces that it has completed the acquisition of privately-held RedWave Technology, a leading provider of portable FTIR spectroscopic analyzers for rapid chemical identification of bulk materials. FTIR (Fourier Transform Infrared), ...

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will report financial results for the first quarter 2024 before market open on Tuesday, April 30, 2024. Company management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time. Live audi...

Thermo Fisher Scientific, Danaher Corporation, and Agilent Technologies are leading companies in the life science tools industry. Despite a long history of success with those firms, I believe long-term investors should diversify into growth opportunities that underlie the industry. 908 Devices, Inc. is a promising company focused on first-in-class mass spectrometry and bioprocess analysis tools...

Robinhood revolutionized commission free investing, and it continues to do so today.

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces the latest in international adoption of the MX908 for trace detection and identification of priority drugs and chemical threats. DrugDetect EU and NATO Support and Procurement Agency (NSPA) have both entered into new contracts to depl...

908 Devices Inc. (NASDAQ:MASS ) Q4 2023 Earnings Conference Call March 5, 2024 8:00 AM ET Company Participants Kelly Gura - IR Kevin Knopp - Co-Founder, CEO, President & Director Joseph Griffith - CFO & Treasurer Conference Call Participants Puneet Souda - Leerink Partners Daniel Arias - Stifel Jacob Johnson - Stephens Matthew Larew - William Blair Operator Hello, everyone, and welcome to the 9...